By Catherine Eckford (European Pharmaceutical Review)2024-04-19T14:47:35
The novel approval provides a dedicated therapy option for patients with ALK-positive early-stage lung cancer.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-30T10:47:00Z
Sponsored by CPhI
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2025-12-03T07:58:01
Sponsored by MBV AG
2025-09-17T08:00:00
Sponsored by Mastercontrol
2025-09-19T15:55:00
Sponsored by Sartorius, By Marko Narobe (Sartorius Biosepartions), Michael Gerrero (BridgeBio) and Srivatsan Ramesh (BridgeBio)
2025-11-05T15:00:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
Site powered by Webvision Cloud